Keyword

odanacatib

Description: Odanacatib is an investigational cathepsin K inhibitor studied as a drug for osteoporosis and bone loss.
Wikidata ID: wiki/Q2014070
OpenAlex ID: keywords/odanacatib
2011 · Tilman D Rachner, Sundeep Khosla, et al. · The Lancet · 3,007
2017 · Sundeep Khosla, Lorenz C Hofbauer · The Lancet Diabetes & Endocrinology · 1,122
2016 · Bente Langdahl, Serge Ferrari, et al. · Therapeutic Advances in Musculoskeletal Disease · 535
2008 · Jacques Yves Gauthier, Nathalie Chauret, et al. · Bioorganic & Medicinal Chemistry Letters · 526
2009 · Henry G Bone, Michael R McClung, et al. · Journal of Bone and Mineral Research · 352
2016 · Sundeep Khosla, Elizabeth Shane · Journal of Bone and Mineral Research · 350
2011 · Aline G. Costa, Natalie E. Cusano, et al. · Nature Reviews Rheumatology · 329
2017 · Matthew T Drake, Bart L Clarke, et al. · Endocrine Reviews · 307
2020 · Rongchen Dai, Zeting Wu, et al. · Frontiers in Cell and Developmental Biology · 246
2015 · Shira D. Halperin, Daniel Kwon, et al. · Organic Letters · 189
2008 · Chad Deal · Nature Clinical Practice Rheumatology · 177
2012 · Bente Langdahl, Neil Binkley, et al. · Journal of Bone and Mineral Research · 166
2016 · Asher Mullard · Nature Reviews Drug Discovery · 160
2011 · E. Michael Lewiecki · Nature Reviews Rheumatology · 159
2011 · G. Mazziotti, J. Bilezikian, et al. · Endocrine · 156
2013 · Marko Novinec, Brigita Lenarčič · Biological Chemistry · 154
2010 · Maxim Frizler, Marit Stirnberg, et al. · Current Topics in Medicinal Chemistry · 132
Works count: 404
Citation count: 15,530
Year
Topic
Type